Gly-Arg-Gly-Asp-Ser,
glycyl-arginyl-glycyl-aspartyl-serine,
GRGDS,
Gly-arg-gly-asp-ser,
96426-21-0,
GRGDS,
H-Gly-Arg-Gly-Asp-Ser-OH,
glycyl-arginyl-glycyl-aspartyl-serine,
CHEMBL417553,
MFCD00076459,
L-Serine, N-(N-(N-(N2-glycyl-L-arginyl)glycyl)-L-alpha-aspartyl)-,
GRGDS Peptide,
C17H30N8O9,
AC1L3XCA,
NH2-Gly-Arg-Gly-Asp-Ser,
SCHEMBL17440322,
RGNVSYKVCGAEHK-GUBZILKMSA-N,
HY-P0295,
BDBM50006330,
BDBM50414896,
ZINC13455558,
AKOS030622941,
NCGC00167212-01,
Gly-Arg-Gly-Asp-Ser, >=97% (HPLC),
LS-178299,
FT-0772116,
L-Serine,glycyl-L-arginylglycyl-L-a-aspartyl-,
(3S)-3-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1,3-dihydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid,
(6S,12S,15S)-1-amino-6-(2-aminoacetamido)-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid,
3-{2-[2-(2-Amino-acetylamino)-5-guanidino-pentanoylamino]-acetylamino}-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid,
D06LKH,
AR-1J3428,
CID123811,
C17-H30-N8-O9,
CS-7044,
l-serine, glycyl-n5-(diaminomethylene)-l-ornithylglycyl-l-|A-aspartyl-,
2611-02-1,